Centralized vaccine procurement in the post-COVID-19 European Union
DOI:
https://doi.org/10.70135/seejph.vi.286Abstract
The COVID-19 pandemic has confronted healthcare systems worldwide with societal, psychological, and economic burdens. The widespread use of the developed COVID-19 vaccines has been generally pursued to stop the spread, decrease mortality rates, and lift the economic burden of healthcare systems. However, it became apparent that the demand for vaccines outnumbers the supply provided by pharmaceutical manufacturers. This policy brief explores the use of centralized procurement globally to formulate recommendations on how the European Union (EU) and its member states can benefit from such an approach.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Author

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.